A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variant.
Sign Up to like & getrecommendations! Published in 2021 at "Cell reports"
DOI: 10.1016/j.celrep.2021.109401
Abstract: Respiratory syncytial virus (RSV) is a major cause of serious acute lower respiratory tract infection in infants and the elderly. The lack of a licensed RSV vaccine calls for the development of vaccines with other… read more here.
Keywords: rsv vaccine; effective mucosal; flagellin variant; rsv phosphoprotein ... See more keywords